Design and synthesis of smalldrug-like molecules using in computational tools for the treatment of cancer, depression and bacterial infections.
Conventional and solid/liquid phase combinatorial synthesis, including microwave-assisted synthesis of novel chemical entities.
Design and development of nano-particulate drug conjugates for targeted drug delivery.
Identification and isolation of structurally novel and biologically active natural compounds for human diseases from medicinal plants.
Department of Pharmaceutical Chemistry extend its wings in the computational(pharmacophore-based virtual screening, 3D-QSAR studies, molecular docking and molecular dynamics) studies andsmall molecule synthesis usingmicrowave and solid-phase synthesis.The department faculty members have high expertise in the computational drug designtools and small molecule drug discovery (synthetic and natural) strategies. Research scholars and postgraduate students are actively engaged in the drug discovery research. Some of the key research activities of department are listed below.
The Department has well equipped research laboratories with several advanced instruments and drug discovery software tools for the synthesis of new chemical entities (NCEs).The laboratories are designed and equipped with several unique features and facilities including a central ventilation system and very sophisticated fume hoods attached to nitrogen, vacuum and water supply.
Department of Pharmaceutical Chemistry involves in the collaborative and interdisciplinary researchwith national and international institutes.
The research outcomes are published in reputed and high-impact factor Journals such as.
Training program: Department conducts several programs including seminars/webinars, symphosia, conferences to enrich the skills on updated techniques and modern tools for the academic and industry peoples.
Consultancy services: Molecular docking, custom synthesis and chemical characterization (FT-IR) studies are provided.
The department is a recognized as a research centreby various funding agencies.
Sl. No. | Name of the Principal Investigator | Title of the Project | Funding agency | Amount(In Lakhs) | Duration |
---|---|---|---|---|---|
1 | Dr.GVS. Ramasarma | R& D Project Substantial grants | AICTE | 3.00 | 1997-98 |
2 | MODROBS | R& D Project Substantial grants | AICTE | 3.00 | 1998-99 |
3 | Dr. S.Badami | Screening and evaluation of anticancer potentials from herbal resources of the Nilgiris | DBT | 16.15 | 2003-06 |
4 | Dr. S. Sankar | EDC Scheme -Medical Transcription programme | AICTE | 8.00 | 2006-09 |
5 | Dr. MJN. Chandrasekar | Targeting anticancer macromolecular prodrugs | DST | 6.26 | 2006-09 |
6 | Dr. S. Sankar | Isolation, screening and characterization of the fertility regulating phyto-constituents present in the traditional plants of the Nilgiris, Derris brevipes, Duriozibenthinus | CSIR | 11.80 | 2009-12 |
7 | Dr. BR. Prasantha Kumar | Computer aided design, synthesis and anti-hyperglycaemic activity of some novel selective glitazones as possible insulin sensitizers | AICTE-RPS | 7.50 | 2010-12 |
8 | Dr. S. Sankar | Synthesis characterization and evaluation of their cytotoxic and antimicrobial activities of some novel heterocyclic compounds | AICTE-RPS | 14.00 | 2011-13 |
9 | Dr. MJN. Chandrasekar | Design, synthesis and evaluation of some novel dipeptidylpeptidase IV inhibitors as antidiabetic agents | UGC | 10.86 | 2011-14 |
10 | Dr. Mohammed Afzal Azam | Phosphodiesterase inhibitors. Design, synthesis and QSAR studies of PDE 4B-inhibitory benzazoles with anti-inflammatory and bronchodilatory activity | DST- SERB | 33.58 | 2013-17 |
11 | Dr. MJN. Chandrasekar | Virtual high throughput screening (vHTS),design,synthesis, invitro/in vivo evaluation and 3D-QSAR investigations of some novel ᵟ - carboline and carbazole lead molecules as antineoplastic agents | DST | 47.66 | 2014-17 |
12 | Mrs. GomathiPriya. J (PI: Dr. MJN. Chandrasekar) | Design virtual screening,synthesis and biological evaluation of Carboline derivatives against antitumor targets. | DST-WOS-A (Women Scientist) | 20.40 | 2015-18 |
13 | Mrs. Ms. Manal M. (PI: Dr. MJN. Chandrasekar) | In silico design of Novel Heterocycles as histone deacetylase inhibitors synthesis and their evaluation for antineoplastic activity | DST-WOS-A (Women Scientist) | 21.00 | 2015-18 |
14 | Ms. Nivishna V. (PI: Dr. MJN. Chandrasekar) | Targeting poly Lmalic acidDoxorubicin nanoparticles to liver cancer | DST-WOS-A (Women Scientist) | 18.60 | 2015-18 |
15 | Dr. MJN. Chandrasekar | Development and Evaluation of Plant based Radioprotective Agents | DRDO | 17.096 | 2015-19 |
16 | Dr. MJN. Chandrasekar | Phase transition mediated targeting of thermosensitive polymerdrug conjugates to human ovarian tumours. | DBT NE | 28.33 | 2016-19 |
17 | Dr. Mohammed Afzal Azam | In Silico Design Synthesis and Evaluation of MurD and MurE Ligase Inhibitors Against Methicillin Resistant Staphylococcus aureus | DST- SERB | 42.591 | 2017-20 |
18 | Dr. S. Jubie | Structure based in-silico docking and rational design of fatty acid synthasethioesterase domain inhibitors as potential anticancer lead compounds. | JSSAHER | 0.40 | 2017-20 |
19 | Dr. R. Kalirajan | Optimization, design and synthesis of novel lead molecules against multiple targets of SARS CoV-2 | MHRD-AICTE DDH Phase-II | 14.353 | 2021-22 |
20 | Dr. S. Jubie | Structure based in-silico docking and rational design of fatty acid synthasethioesterase domain inhibitors as potential anticancer lead compounds. | JSSAHER | 0.40 | 2017-20 |
21 | Dr. B. Gowramma | Design synthesis and evaluation of novel 1,3,4thiadiazole derivatives as gamma secretase inhibitors for the treatment of breast cancer. | JSSAHER | 0.50 | 2017-20 |
22 | Dr. S. Gomathy | Design synthesis of novel fourthiazolidinone derivatives and antiParkinsons agents. | JSSAHER | 0.50 | 2017-20 |
Sl. No. | Name of the Principal Investigator | Title of the Project | Funding agency | Amount(In Lakhs) | Duration |
---|---|---|---|---|---|
1 | Dr. S. Gomathi Swaminathan | Central Neuroprotective evaluation of heterocyclic compounds as p2x7 receptor antagonists | ICMR, New Delhi | 17.73 | 2022 - 2025 |
2 | Dr. S. Jubie | An integrated drug discovery approach to identify new family of HIF -1 alpha mimetics for diabetic wound repair treatment (Dec 2023 – Nov 2026) | ICMR, New Delhi | 42.82 | 2023 - 2026 |
3 | Dr. R. Kalirajan | In silico design synthesis of novel acridine derivatives for targeting breast cancer | JSSAHER | 0.50 | 2021-23 |
4 | Dr. Gomathi swaminathan | Phytochemical and Pharmacological Evaluation of PithecellobiumdulceBenth Leaves against Chronic Alcohol induced Cognitive Impairment. | JSSAHER, Mysuru | 0.50 | 2021-23 |
5 | Dr. Srikanth Jupudi | Repurposing FDA Approved Drugs for Myobacterium tuberculosis MurD and Mur ELigases A Preliminary Investigation. | JSSAHER, Mysuru | 0.50 | 2021-23 |
6 | Dr. S. Jubie | Synthesis and characterization of carbon nano tubes bearing drugs identified through net work aided in-silico approach for breast cancer therapy; A novel drug repurposing strategy | JSS AHER, Mysuru | 0.50 | 2021-24 |
7 | Dr. B. Gowramma | Design, synthesis and anticancer evaluation of PAPRI inhibitor bearing novel heterocyclic moiety | JSSAHER, Mysuru | 1.50 | 2023-26 |
8 | Dr. S. Gomathy | Synergistic Neuroprotective potential of fenofibric acid & quercetin loaded solid liphid nanoparticle: promoting lysosomal autophagy 7 the cleavage of RAGE receptor via PPAR-a &TFEB activation in Parkinson’s disease | JSSAHER, Mysuru | 3.00 | 2023-26 |
Sl. No. | Name of PhD scholar | Fellowship awarding agency & scheme | Fellowship amount (Rs in lakhs) | Duration |
---|---|---|---|---|
1 | Mr. Ankur Gupta | AICTE-NDF | 2.61 | 2011-13 |
2 | Mr. Pankaj Masih | ICMR- SRF | 2.62 | 2011-13 |
3 | Mr. Hemnath E | JSS AHER | 0.60 | 2013-14 |
4 | Mr. Naga Srinivas Tripuraneni | DST-SRF | 08.64 | 2014-16 |
5 | Mr. Jayaram U | UGC-RGNF- SRF | 9.36 | 2015-17 |
6 | Mr. Janarthanan T | ICMR- SRF | 6.48 | 2015-17 |
7 | Mr. Prasanth Francis | DBT-RA | 8.71 | 2015-17 |
8 | Mr. Srikanth Jupudi | DST-SRF | 12.09 | 2017-19 |
9 | Mr. Selvaraj. A | DBT, (JRF/SRF) | 6.60 | 2015-17 |
10 | Ms. Pandiselvi | AICTE - QIP | 5.40 | 2017-20 |
11 | Mr. Santhosh. S.B | DBT, (JRF/SRF) | 10.29 | 2017-19 |
12 | Mr.Niladiri Saha | DST - SERB | 3.88 | 2018-21 |
13 | Ms. Swaroopa Rani Gurram | AICTE - QIP | 5.40 | 2018-21 |
14 | Mr. Kaviarasan.L | AICTE - NDF | 10.68 | 2018-21 |
15 | Ms.Yele Vidyasrilekha | AICTE - NDF | 10.68 | 2018-21 |
16 | Mr. Sunil Kumar Patnaik | DRDO | 10.08 | 2018-20 |
17 | Mr. Sunil Kumar Patnaik | JSS AHER | 1.20 | 2021-22 |
18 | Ms. Gomathi Priya J | DST-WOS-A | 20.40 | 2018-21 |
19 | Ms. Nivishna V | DST-WOS-A | 18.60 | 2018-21 |
20 | Ms. Manal M | DST-WOS-A | 21.00 | 2018-21 |
21 | Ms. Gomathi Priya J | ICMR(RA) | 14.15 | 2019-21 |
22 | Mr. Selvaraj. A | ICMR(SRF) | 11.08 | 2019-21 |
23 | Ms. Deepthi Ramamurthi | ICMR(SRF) | 13.60 | 2019-21 |
24 | Mrs. Farhath Sherin | ICMR(SRF) | 13.60 | 2019-22 |
25 | Mr. Palathoti Nagarjuna | Lady TATA Memorial Trust-JRF | 23.04 | 2023-27 |
26 | Mr. Podila Naresh | JSS AHER, Mysuru | 1.20 | 2019-20 |
27 | Mr. Podila Naresh | JSS AHER, Mysuru | 0.25 | 2019-20 |
28 | Mr. Pulla Prithvi Raj | JSS AHER, Mysuru | 1.20 | 2019-20 |
29 | Mr. Shyam Sundar P | JSS AHER, Mysuru | 1.20 | 2020-21 |
30 | Mr. Shyam Sundar P | JSS AHER, Mysuru | 0.25 | 2020-21 |
31 | Mr. P. Varakumar | JSS AHER, Mysuru | 1.20 | 2021-22 |
32 | Mrs. Baliwada Aparna | JSS AHER, Mysuru | 1.20 | 2021-22 |
33 | Mr. Kannan.R | JSS AHER, Mysuru | 1.20 | 2022-23 |
34 | Mr. Mohammed Zubair Baba | JSS AHER, Mysuru | 1.20 | 2022-23 |
35 | Mr. Palathoti Nagarjuna | JSS AHER, Mysuru | 1.20 | 2022-23 |
36 | Mr. Jagadish Chand | JSS AHER, Mysuru | 1.20 | 2022-23 |
37 | Mr. Akey Krishna Swaroop | JSS AHER, Mysuru | 1.20 | 2022-23 |
38 | Cardilya A P | JSS AHER, Mysuru | 1.20 | 2020-21 |
39 | Mr. Umair Wahedi | JSS AHER, Mysuru | 1.20 | 2022-23 |
40 | Mr. Mohammed Zubair Baba | JSS AHER, Mysuru | 0.25 | 2022-23 |
41 | Mr. Umair Wahedi | JSS AHER, Mysuru | 0.25 | 2022-23 |
42 | Mr. Jagadish Chand | JSS AHER, Mysuru | 0.25 | 2022-23 |
43 | Mr. Akey Krishna Swaroop | JSS AHER, Mysuru | 0.25 | 2022-23 |
44 | Esakki Muthu Kumar M | JSS AHER, Mysuru | 1.60 | 2023-24 |
45 | Koppula Jayanthi | JSS AHER, Mysuru | 1.60 | 2023-24 |
46 | Ms. Abisha Thomas | JSS AHER, Mysuru | 1.60 | 2023-24 |
47 | Ms. Neeru Dugar | JSS AHER, Mysuru | 1.60 | 2023-24 |
48 | Ms. Abisha Thomas | JSS AHER, Mysuru | 0.25 | 2023-24 |
49 | Ms Saranya R | JSS AHER, Mysuru | 1.60 | 2023-24 |
50 | Mr. Dhinesh Kumar M | JSS AHER, Mysuru | 1.60 | 2023-24 |
51 | Mr. Dhinesh Kumar M | JSS AHER, Mysuru | 0.25 | 2024-25 |
Mrs. Pandiselvi
Mr. Sunil Kumar Patnaik
Mr. Pulla Prudvi Raj
Ms. Jayanthi
Mr. Zubair
Ms. Aparna
Mr. Kannan
Mr A K Swaroop
Mr. Zubair
Ms S Priyadarshini
Mr Palathothi Nagarjuna
MS. Abisha Thomas
Sl. No. | Name of Programme | Title of the programme | Name of the funding agency | Grant amount (Rupees in Lakhs) | Period |
---|---|---|---|---|---|
1 | Quality Improvement Programme | Recent Advances in Pharmaceutical Chemistry | AICTE | 0.50 | 28 May -10 June, 2001 |
2 | Quality Improvement Programme | Modern trends in Pharmaceutical Chemistry | AICTE | 1.0 | 7-8 February, 2006 |
3 | Quality Improvement Programme | Approaches to Drug Development | AICTE | 1.0 | 30 March – 5 April 2007 |
4 | Quality Improvement Programme | Trends in drug discovery & Drug development | AICTE | 1.0 | 9-22 February, 2008 |
5 | Quality Improvement Programme | Modern Techniques in Pharmaceutical Chemistry and Pharmaceutical Analysis | AICTE | 5.0 | 14-27 March , 2011 |
6 | Quality Improvement Programme | Emerging trends in Pharmaceutical Chemistry and Pharmaceutical Analysis | AICTE | 5.0 | 1-15 September, 2014 |
7 | Quality Improvement Programme | Advanced Instrumental Techniques and Data Acquisition in Pharmacological Research | AICTE | 5.0 | 13-26 March, 2017 |
8 | Short term Training Programme | Recent advances in drug discovery development and lead optimization.(3 Modules) | AICTE | 3.0 | Module-I (10 – 15 August2020) Module-II (07-12 September.2020) Module-III (05- 10 October.2020) |
Department of Pharmaceutical Chemistry Consultancy work
Industry/Academic | Institute/Organization | Total Amount (in Rs.) |
---|---|---|
Consultancy from Industry | 1. CIRA Herbals L.L.P, Mumbai 2. Glide Chem Pvt., Ltd., New Delhi 3. Gulbrandsen Technologies (India) Pvt Ltd., Gujarat |
12,81,000/- |
Consultancy from Academic and Research institutions | 1. Lovely Professional University, Punjab 2. DPSRU. New Delhi 3. PES Rajaram College of Pharmacy, GOA 4. Sri Ramachandra Institute of Higher Education & Research, Chennai, TN 5. Annamalai university, Chidambaram, TN 6. Anurag university 7. Sri Padmavathi Mahila University, Tirupathi, AP 8. Vinayaka missions College of Pharmacy, Salem, TN 9. KM college of pharmacy, Madurai, TN 10. Avinashilingam college, Coimbatore 11. PSG College of Arts and Science, Coimbatore 12. NIPER, Hijapur 13. SRM Institute of science & Technology 14. PES Rajaram College of Pharmacy, GOA 15. Mallareddy College of Pharmacy, Telengana 16. Karpagam Academy of Higher Education, CBE 17. Westfort College of Pharmacy, Trissur, KL 18. JKKM College of Pharmacy, Komarapalayam 19. KK College of Pharmacy, Chennai 20. Ultra College of Pharmacy, Madurai 21. PSG College of Arts and Science, Coimbatore |
5,51,000/- |
Sl. No. | Title of Patent | Patent/Application No. | Name of Inventor(s) | Status | Year |
---|---|---|---|---|---|
1 | Thiazolidine-2, 4diones and process thereof | 245830 | Dr. M.J Nanjan Dr. B.R. Prasantha Kumar, Dr. Bhojraj Suresh | Awarded | 2011 |
2 | Process for isolation of bergenin fromCaesalpinia digyna Rottler | 286441 | Dr.M.J Nanjan, Dr. R. Srinivasan, Dr. MJN Chandrasekar | Awarded | 2017 |
3 | Novel Glitazones Incorporated With Tyrosine: Synthesis And Antidiabetic Activity | 284768 | Dr.M.J Nanjan, Dr. BR. Prashantha kumar | Awarded | 2017 |
4 | Isolation of sulphaquinovosyldiacyl glycerol (SL) (A human topoposition 1) using flash chromatography | IN:352435 | Dr.S.P.Dhanabal, Dr.S.Jubie, Mr.MVNL. Chaitanya | Awarded | 2020 |
5 | Novel Glitazones as Ppar-α And Ppar-γ Agonists And α-Glucosidase Inhibitors | IN:382881 | Dr.M.J Nanjan, Dr. T.K Praveen, Dr. MJN Chandrasekar | Awarded | 2021 |
6 | Isolation of 5-heptadeca-5,8,11-trienyl 1,3,4- oxadiazole -3-thio (GLA-1) as a novel human topoposition lead | IN:365340 | Dr.S.P.Dhanabal, Dr.S.Jubie, Mr.MVNL. Chaitanya | Awarded | 2021 |
7 | 2-oxo-2H-chromen-4-yl 1hbenzo [d] imidazole- 2(3H)-ylidene sulfamate and its functionalized carbon nanotubes thereof for treatment of breast cancer | IN:393780 | Jubie Selvaraj, Jawahar Natarajan, Gowthamarajan Kuppusamy, Dhanabal Palanisamy | Awarded | 2022 |
8 | Mono-esterification process for the synthesis of carboxymethyl chitosan hybrid with WZB117 | IN:408278 | K.Gowthamarajan, S.Jubie, Anindita De | Awarded | 2022 |
9 | Method for quantification of degradation products formed during forced degradation studies for raltegravir | IN:482389 | Krishnaveni Nagappan, Sonam Patel, Mariraju Jeyaprakash, Jubie selvaraj | Awarded | 2023 |
10 | “(2-((E)-7-hydroxy-4-methyl-2H-chromen-2-ylidene)-N-((E)-2-nitrobenzylidene) hydrazine-1-carbothioamide), BRCA-1 mimetic useful for breast cancer treatment. | IN:514580 | Selvaraj, Jubie, Pottabathula, Shyam Sundar, Swaroop, Akey Krishna, Dhanabal, Palanisamy | Awarded | 2024 |
11 | Donepezil Loaded Lipid Coated Nanoceria from Effective Management of Alzheimer’s Disease | IN:496294 | Jawahar Natarajan, Venkatachalam Senthil, Jubie Selvaraj, Dhanabal Palanisamy | Awarded | 2024 |
12 | A Chlorine Estimating and Stabilizing Apparatus and Method Thereof | 202241045534A | M. Anand, Dr. R. Kalirajan, Potlapati Varakumar, Kannan R | Published | 2022 |
13 | Novel Chromen-3-yl-Carbamate Derivatives and Their Effectiveness as The Inhibitorsof SARS-CoV-2 Virus 3cl Protease Enzyme | 202341051234A | Dr. Kalirajan Rajagopal, Mr. Kannan Raman, Dr.Srikanth Jupudi, Dr .Gowramma Byran, Sankaranarayanan Murugesan | Published | 2023 |
14 | A Biodegradable Panty-Type Sanitary Menstruation Undergarment and A Process of Making Thereof | 202341060893A | Dr. Gomathi Swaminathan, Dr. Kalirajan Rajagopal, Mr. Kannan Raman, Ms. J. Rebekal, Dr. Srikanth Jupudi, M. Anand | Published | 2023 |
15 | Fast Dissolving Oral Thin Films of Cetirizine Hydrochloride and Preparation Method Thereof | 202341027299A | Dr. M. Kishore Babu, SK Rubina, Mr. Bharadhan Bose, Dr N M Vageesh, Dr. Kalirajan Rajagopal, Shabana Parveen, Dr. Karthickeyan Krishnan, Katroju Neelima Santhoshi, Dr. Prakash Srichand Sukhramani, Mekala Sumathi | Published | 2023 |
16 | Herbal formulation for the prevention and treatment of diabetes mellitus | 202341034925A | Dr. Kalirajan Rajagopal, Dr. Ajay Kumar Gupta, M A Rahman, Dr. Gomathi Swaminathan, Dr. R. Sambathkumar, Mr. Kannan Raman, Dr. C. Kannan, Dr. Srikanth Jupudi, Mr. Rishabh Khare, Dr. Sudhahar Dharmalingam, Bhavya Agarwal, Dr. Amit Upadhyay, Dr. Nilima Shukla | Published | 2023 |
17 | 1-[(1H-IMIDAZOL-1-YL) METHYL]-3,5-DIPHENYL-1H-PYRAZOLE USEFUL IN DIABETIC WOUND TREATMENT | 202341058324 | Jubie Selvaraj, EsakkiMuthukumar Mariappan, AkeyKrishna Swaroop, Natarajan Jawahar, Palanisamy Dhanabal | Published | 2023 |
18 | A Composition for Nasal Inhalation | 202241024942 | Jawahar Natarajan, Nidamanuri Bala Sai Soujith, Rajeshkumar Raman, Selvaraj Jubie, Venkatachalam Senthil, Dhanabal Palanisamy | Published | 2023 |
19 | 1,3,4-Thiadiazolo (3,2-Α) Pyrimidine-6-Carbonitrile Compound as PARP1 Inhibitors | 202141032777 | Byran Gowramma, Lakshmanan Kaviarasan, Eldhose Eliizabeth, Rajagopal Kalirajan, Krishnamurthy Praveen Thaggikuppe, Subramanian Gomathy | Published | 2023 |
20 | 2-(1-substituted-1H-benzo[d]imidazol-2-yl)-N acetamide compounds having dual inhibitory activity | 202141042924 | Byran Gowramma, Lakshmanan Kaviarasan, Rajagopal Kalirajan, Subramania Nainar Meyyanathan, Krishnamurthy Praveen Thaggikuppe, Niraikulam Ayyadurai | Published | 2023 |
21 | DESIGN, SYNTHESIS OF NOVEL N-(ACRIDIN-9-YL)-4-(5-PHENYLISOXAZOL-3-YL) BENZAMIDE DERIVATIVES AND THEIR PHARMACOLOGICAL EVALUATION AGAINST BREAST CANCER | 202441034284 A | Dr. Kalirajan Rajagopal, Ms. Pandiselvi Arumugasamy, Mr. Kannan Raman, Dr .Gowramma Byran, Dr. Gomathi Swaminathan, M. Anand | Published | 2024 |
22 | IOT Enabled Laboratory Ultrasonicator for Nanoparticle Synthesis | 398361-001 | Dr. Kalirajan Rajagopal, Mr. Kannan Raman, Dr. Gowramma Byran, Dr. Srikanth Jupudi, Mr. Dhineshkumar M, Mr. Krutheesh, Ms. Anuj | Published | 2024 |
23 | Fluid Monitoring System | 202241041101A | M. Anand, Dr. R. Kalirajan, Dr. Arun R, Mrs. Rubini. S | Published | 2024 |
24 | Indole triazole conjugates as anti-bacterial agents | 202141003113 | Md. Afzal Azam, Vidya srileka, Bharat Kumar Reddy Sanapalli Dr. Ashish Wadhwani | Filed | 2021 |
25 | “3-(5-benzyl-1, 3, 4-oxadiazol-2-yl)-2-substituted phenyl thiazolidin-4-one, as sirt-3 activators, and process for preparation there of” | 202241003547 | Subramanian Gomathy, Krishnamurthy Praveen Thaggikuppe, Selvaraj Jubie, Byran Gowramma | Filed | 2022 |
26 | An interleukin-6 inhibitor for treating autoimmune disorders | 202441024981 | Jubie Selvaraj, Akey Krishna Swaroop, Esakkimuthukumar M,Jawahar Natarajan | Filed | 2024 |
Sl. No. | Authors | Title of the book published | Name of the Publisher | National / International | ISBN/ ISSN | Year of publication |
---|---|---|---|---|---|---|
1 | Dr. Kalirajan Rajagopal | Medicinal Chemistry 1 | AD Medical Publication, Kilakarai, Tamilnadu | National | 978-93-5396-937-0 | 2020 |
2 | Dr. Kalirajan Rajagopal | Practical manual for I. Phram D_Pharmaceutical Organic Chemistry | JSS College of Pharmacy, Ooty | National | 978-93-5619-980-4 | 2021 |
3 | Dr. Kalirajan Rajagopal | Practical manual for III. Phram D_Medicinal Chemistry | JSS College of Pharmacy, Ooty | National | 978-93-5620-388-4 | 2021 |
4 | Dr. S. Jubie | Practical Manual of Medicinal Chemistry III | JSS College of Pharmacy, Ooty | National | 978-93-5493-430-8 | 2021 |
5 | Dr. S. Jubie | Practical manual of Pharm. Organic Chemistry II | JSS College of Pharmacy, Ooty | National | 978-93-5566-965-0 | 2021 |
6 | Dr. S. Jubie | A Text book of Computer aided drug design | ScienTech | National | 978-81-9501-972-4 | 2020 |
7 | Dr. S. Jubie | Chapter fatty acids and their analogues anticancer agents | INTECH Open access | International | 978-953-51-5279-8 | 2017 |
8 | Dr. Gowramma B | Practical Manual of Pharmaceutical Organic Chemistry I | JSS College of Pharmacy, Ooty | National | 978-93-5607-575-7 | 2021 |
9 | Dr. Gowramma B | Practical Manual of Pharmaceutical InOrganic Chemistry | JSS College of Pharmacy, Ooty | National | 978-93-5620-718-9 | 2021 |
10 | Dr. Gowramma B | Enantiomeric separation of Valgancicllovir by HPLC and L/MS methods | LAP LAMBERT Academic Publisher, Germany | International | 978-620-2-55430-5 | 2019 |
11 | Dr. Gomathy S | Practical Manual of Medicinal Chemistry I | JSS College of Pharmacy, Ooty | National | 978-93-5607-209-1 | 2021 |
12 | Dr. Gomathy S | Practical Manual of Pharmaceutical Inorganic Chemistry Pharm D | JSS College of Pharmacy, Ooty | National | 978-93-5627-823-3 | 2021 |
13 | Dr. Gomathy S | Practical manual of Pharmaceutical Chemistry I | JSS College of Pharmacy, Ooty | National | 978-93-5636-798-2 | 2021 |
14 | Dr. T Durai Ananda Kumar | Drug design: a conceptual overview | CRC London | International | 978-10-32288-42-0 | 2022 |
15 | Dr. T Durai Ananda Kumar | Current Concepts in Drug Design | PharmaMed press, BSP Books, Hyderabad | National | 978-93-87593-83-1 | 2020 |
16 | Dr. T Durai Ananda Kumar | Microwave Assisted Chemistry Experiments (Organic, Synthesis, Chemical Analysis and Extraction) | PharmaMed press, BSP Books, Hyderabad | National | 978-93-89974-90-4 | 2020 |
17 | Dr. T Durai Ananda Kumar | Computers in drug Development | Vallabh Prakashan, New Delhi | National | 978-93-85529-28-3 | 2020 |
18 | Dr. T Durai Ananda Kumar | Experimental Organic Medicinal Chemistry-Principles and Practice | PharmaMed press, BSP Books, Hyderabad | National | 978-9352300792 | 2015 |
19 | Dr. T Durai Ananda Kumar | Elementary Pharmacoinformatics | PharmaMed press, BSP Books, Hyderabad | National | 978-9385433665 | 2014 |
20 | Dr. Gomathi Swaminathan | Pharmacological Evaluation of Plant Derived Flavonoid Hesperidin | LAP LAMBERT Academic Publisher, Germany | International | 978-620-2-68151-3 | 2020 |
20 | Dr. Gomathi Swaminathan | New Concepts in Pharmaceutical Organic Chemistry-II | PV Books, S. Vikas and Company (Medical Publisher) | National | 97815-43344-11-0 | 2020 |
21 | Dr. Gomathi Swaminathan | Phytochemical and Neuroprotective evaluation of Pedalium murex Linn Leaf | LAP LAMBERT Academic Publisher, Germany | International | 978-3-659-79348-6 | 2019 |
22 | Dr. Gomathi Swaminathan | Phytochemical and Pharmacological Assessment of Leucas aspera | LAP LAMBERT Academic Publisher, Germany | International | 978-620-4-72629-8 | 2022 |
23 | Dr. Gomathi Swaminathan | Practical Manual of Medicinal Biochemistry | JSS College of Pharmacy, Ooty | National | 978-93-5593-618-9 | 2021 |
24 | Dr. Gomathi Swaminathan | Practical Manual of Medicinal Chemistry | JSS College of Pharmacy, Ooty | National | 978-93-5627-265-1 | 2021 |
25 | Dr Srikanth Jupudi | Practical manual of Pharmaceutical Chemistry II | JSS College of Pharmacy, Ooty | National | 978-93-5593-078-1 | 2021 |